Greater use of in-patient diagnostic imaging improves patient outcomes without significantly impacting costs

Oct 28, 2009

Hospitals that make greater use of inpatient diagnostic imaging exams achieve lower in-hospital mortality rates with little or no impact on costs, according to a peer-reviewed study of more than 1 million patient outcomes in more than 100 hospitals nationwide published in the November issue of the Journal of the American College of Radiology (JACR).

"The results of our in-depth study would indicate that greater use of imaging does, in fact, lead to better patient outcomes in terms of lower in-hospital death rates with no significant impact on overall cost," said David W. Lee, Ph.D., lead author of the article and Senior Director, Health Economics and Outcome Research at GE Healthcare. "This study dealt only with imaging provided in hospitals, but would seem to confirm what many have long suspected — that medical imaging exams save lives."

Researchers examined data from the Thomson Reuters Drug Database (HDD) exploring the association between the utilization of diagnostic imaging services and two key hospital outcome measures: mortality and costs. Their analysis examined data from inpatient admissions that occurred during 2007 in the 102 hospitals in the HDD that provided sufficiently detailed data to support assessment of the utilization of inpatient diagnostic services. The study included all clinical conditions treated in-hospital, assessing the experience of patients with private, commercial and governmental-sponsored insurance.

"Because use of imaging procedures grew rapidly in the early parts of this decade, payers and policymakers have questioned whether more use is associated with better health outcomes. Based on our research, the answer would appear to be yes," said Lee.

Source: American Roentgen Ray Society

Explore further: Elan holders OK buyback, vote down three deals

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

FDA approves new silicone breast implants

11 hours ago

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

New language discovery reveals linguistic insights

A new language has been discovered in a remote Indigenous community in northern Australia that is generated from a unique combination of elements from other languages. Light Warlpiri has been documented by University of Michigan ...